AAPL   320.77 (+0.89%)
MSFT   182.51 (-0.40%)
FB   229.03 (+1.75%)
GOOGL   1,435.32 (+0.13%)
AMZN   2,468.50 (+1.07%)
NVDA   351.21 (-1.07%)
BABA   205.43 (-0.95%)
MU   46.78 (-2.36%)
GE   6.72 (+2.28%)
TSLA   878.00 (+5.15%)
AMD   53.34 (-0.86%)
T   31.09 (+0.75%)
ACB   13.98 (-0.71%)
BAC   24.62 (+2.03%)
BA   151.15 (+3.63%)
AAPL   320.77 (+0.89%)
MSFT   182.51 (-0.40%)
FB   229.03 (+1.75%)
GOOGL   1,435.32 (+0.13%)
AMZN   2,468.50 (+1.07%)
NVDA   351.21 (-1.07%)
BABA   205.43 (-0.95%)
MU   46.78 (-2.36%)
GE   6.72 (+2.28%)
TSLA   878.00 (+5.15%)
AMD   53.34 (-0.86%)
T   31.09 (+0.75%)
ACB   13.98 (-0.71%)
BAC   24.62 (+2.03%)
BA   151.15 (+3.63%)
AAPL   320.77 (+0.89%)
MSFT   182.51 (-0.40%)
FB   229.03 (+1.75%)
GOOGL   1,435.32 (+0.13%)
AMZN   2,468.50 (+1.07%)
NVDA   351.21 (-1.07%)
BABA   205.43 (-0.95%)
MU   46.78 (-2.36%)
GE   6.72 (+2.28%)
TSLA   878.00 (+5.15%)
AMD   53.34 (-0.86%)
T   31.09 (+0.75%)
ACB   13.98 (-0.71%)
BAC   24.62 (+2.03%)
BA   151.15 (+3.63%)
AAPL   320.77 (+0.89%)
MSFT   182.51 (-0.40%)
FB   229.03 (+1.75%)
GOOGL   1,435.32 (+0.13%)
AMZN   2,468.50 (+1.07%)
NVDA   351.21 (-1.07%)
BABA   205.43 (-0.95%)
MU   46.78 (-2.36%)
GE   6.72 (+2.28%)
TSLA   878.00 (+5.15%)
AMD   53.34 (-0.86%)
T   31.09 (+0.75%)
ACB   13.98 (-0.71%)
BAC   24.62 (+2.03%)
BA   151.15 (+3.63%)
Log in

ETR:COPCompugroup Medical Stock Price, Forecast & News

€73.35
+1.15 (+1.59 %)
(As of 06/1/2020 12:33 PM ET)
Add
Compare
Today's Range
€71.30
Now: €73.35
€74.35
50-Day Range
€62.70
MA: €70.74
€76.35
52-Week Range
€46.46
Now: €73.35
€78.50
Volume114,572 shs
Average Volume68,245 shs
Market Capitalization$3.55 billion
P/E Ratio62.16
Dividend Yield0.68%
BetaN/A
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks. This segment offers integrated software solutions for customers to manage, analyze, and use medical data; organize business operations; and generate invoices. Its Pharmacy Information Systems segment provides integrated clinical, administrative, and financial software applications for retail pharmacies. This segment also offers in-store and online merchandising programs. The company's Hospital Information Systems segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute hospitals; rehabilitation centers; and social services, including multi-site hospital networks and regional care organizations. Its Health Connectivity Services segment provides solutions that enable pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment also offers clinical decision support systems, and drugs and therapy databases for healthcare providers; and solutions for personal health records, consumer portals, and mobile applications, as well as collects and mediates clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical Aktiengesellschaft and changed its name to CompuGroup Medical Societas Europaea in February 2016. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany.
Read More
Compugroup Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.24 out of 5 stars


Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone+49-261-80000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$781.26 million
Cash Flow€1.28 per share
Book Value€5.58 per share

Profitability

Miscellaneous

Employees5,000
Market Cap$3.55 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive COP News and Ratings via Email

Sign-up to receive the latest news and ratings for COP and its competitors with MarketBeat's FREE daily newsletter.

Compugroup Medical (ETR:COP) Frequently Asked Questions

How has Compugroup Medical's stock been impacted by COVID-19 (Coronavirus)?

Compugroup Medical's stock was trading at €55.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, COP shares have increased by 32.9% and is now trading at €73.35. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Compugroup Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Compugroup Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Compugroup Medical.

When is Compugroup Medical's next earnings date?

Compugroup Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Compugroup Medical.

What price target have analysts set for COP?

6 Wall Street analysts have issued 1 year price objectives for Compugroup Medical's shares. Their forecasts range from €59.00 to €80.00. On average, they anticipate Compugroup Medical's stock price to reach €68.17 in the next year. This suggests that the stock has a possible downside of 7.1%. View analysts' price targets for Compugroup Medical.

Has Compugroup Medical been receiving favorable news coverage?

News coverage about COP stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Compugroup Medical earned a news impact score of 1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutCompugroup Medical.

Who are some of Compugroup Medical's key competitors?

What other stocks do shareholders of Compugroup Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Compugroup Medical investors own include Whiting Petroleum (WLL), Hollywood Media (HOLL), Whiting Canadian (KOG), Netflix (NFLX), Vaccinex (VCNX), Whiting USA Trust II (WHZT), Applegreen (APGN), Apple Hospitality REIT (APLE), Hollywood Bowl Group (BOWL) and Compugen (CGEN).

Who are Compugroup Medical's key executives?

Compugroup Medical's management team includes the following people:
  • Mr. Frank Gotthardt, Chairman of Management Board & CEO (Age 69)
  • Mr. Christian Bartlett Teig, CFO & Member of Management Board (Age 54)
  • Mr. Uwe Eibich, Exec. VP of Telematics & eHealth Platforms and Member of Management Board (Age 57)
  • Mr. Hannes Reichl, Member of Exec. Board
  • Mr. Frank Brecher, Chief Process Officer & Member of Management Board (Age 49)

What is Compugroup Medical's stock symbol?

Compugroup Medical trades on the ETR under the ticker symbol "COP."

What is Compugroup Medical's stock price today?

One share of COP stock can currently be purchased for approximately €73.35.

How big of a company is Compugroup Medical?

Compugroup Medical has a market capitalization of $3.55 billion and generates $781.26 million in revenue each year. Compugroup Medical employs 5,000 workers across the globe.

What is Compugroup Medical's official website?

The official website for Compugroup Medical is www.cgm.com.

How can I contact Compugroup Medical?

Compugroup Medical's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.